Parkinson’s Disease and Environmental Toxicants
Parkinson’s disease is the second most common neurodegenerative disorder, characterized by loss of dopaminergic neurons in the substantia nigra. Emerging evidence links PFAS exposure to accelerated neurodegeneration.
Mechanistic Pathways
PFAS compounds disrupt mitochondrial function, increase oxidative stress, and impair dopamine synthesis. Animal studies show that PFAS exposure reduces tyrosine hydroxylase expression, a key enzyme in dopamine production, mimicking early Parkinson’s pathology.
Epidemiological Evidence
Occupational cohort studies of PFAS-exposed workers show elevated rates of Parkinson’s-like symptoms compared to unexposed controls. Communities near PFAS manufacturing sites report higher rates of tremor and movement disorders.
Protective Strategies
Reducing PFAS exposure through filtered drinking water may lower neurological risk. Antioxidant-rich diets, exercise, and monitoring of neurological symptoms are recommended for high-exposure populations.